Retatrutide is a triple receptor agonist acting on GIP, GLP-1, and glucagon receptors. The added glucagon activity is studied for its potential effect on energy expenditure alongside appetite and glucose pathways, and early research has reported substantial weight changes. Supplied as a lyophilized powder for reconstitution. Strictly for research use.
No offers match your filters
Try clearing the vendor, stock, or dosage filters.